The role of serological components in causing cardiovascular damage in COVID-19 is further corroborated by a significant negative correlation of IL-6, TNF-α, IL-1β, IL-10, and CRP levels with cardiomyocyte viability (Figure 3B). This evidence concerns the gene IL6 and COVID-19.